Key facts
- Notable investors include True North Venture Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Acuriant
- ·The full record, as it builds
Funding rounds
No funding rounds for Acuriant are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Acuriant
Operator of an advanced membrane filtration technology company intended to solve the world's toughest separation and purification challenges across industrial and municipal sectors. The company offers a hybrid ceramic-polymeric membrane platform combining robust ultrafiltration with precision-engineered polymeric systems, enabling customers in industries such as dairy, food & beverage, life sciences and water treatment to achieve superior yield, sustainability and cost-efficiency through tailored separation solutions.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Employees
- 250
- Website
- acuriant.com/
- Ownership
- Privately Held (backing)
Acuriant doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Acuriant shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Acuriant in its N-PORT filings yet. We sweep new filings monthly.